[HTML] cell.comFull View

[HTML][HTML] Prevention and therapy of SARS-CoV-2 and the B. 1.351 variant in mice

DR Martinez, A Schäfer, SR Leist, D Li, K Gully… - Cell reports, 2021 - cell.com
Improving clinical care for individuals infected with SARS-CoV-2 variants is a global health
priority. Small-molecule antivirals like remdesivir (RDV) and biologics such as human …
被引用次数：44 相关文章
[PDF] core.ac.uk

[PDF][PDF] Prevention and therapy of SARS-CoV-2 and the B. 1.351 variant in mice

DR Martinez, A Schafer, SR Leist, D Li, K Gully… - Cell Reports, 2021 - core.ac.uk
Improving clinical care for individuals infected with SARS-CoV-2 variants is a global health
priority. Smallmolecule antivirals like remdesivir (RDV) and biologics such as human …
[PDF] scienceopen.com

[PDF][PDF] Prevention and therapy of SARS-CoV-2 and the B. 1.351 variant in mice

DR Martinez, A Schaefer, SR Leist, D Li, K Gully - scienceopen.com
Improving the standard of clinical care for individuals infected with SARS-CoV-2 32 variants
is a global health priority. Small molecule antivirals like remdesivir (RDV) and 33 biologics …

[引用][C] Prevention and therapy of SARS-CoV-2 and the B. 1.351 variant in mice

DR Martinez, A Schäfer, SR Leist, D Li, K Gully… - Cell Reports, 2021 - cir.nii.ac.jp
Prevention and therapy of SARS-CoV-2 and the B.1.351 variant in mice | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …

Prevention and therapy of SARS-CoV-2 and the B. 1.351 variant in mice

DR Martinez, A Schäfer, SR Leist, D Li… - Cell …, 2021 - pubmed.ncbi.nlm.nih.gov
Improving clinical care for individuals infected with SARS-CoV-2 variants is a global health
priority. Small-molecule antivirals like remdesivir (RDV) and biologics such as human …

Prevention and therapy of SARS-CoV-2 and the B. 1.351 variant in mice

DR Martinez, A Schaefer, SR Leist, D Li, K Gully… - bioRxiv, 2021 - biorxiv.org
Improving the standard of clinical care for coronavirus disease 2019 (COVID-19) is a global
health priority. Small molecule antivirals like remdesivir (RDV) and biologics such as human …
[HTML] europepmc.org

[HTML][HTML] Prevention and therapy of SARS-CoV-2 and the B. 1.351 variant in mice

DR Martinez, A Schaefer, SR Leist, D Li, K Gully… - 2021 - europepmc.org
Improving the standard of clinical care for individuals infected with SARS-CoV-2 variants is a
global health priority. Small molecule antivirals like remdesivir (RDV) and biologics such as …
[HTML] nih.gov

[HTML][HTML] Prevention and therapy of SARS-CoV-2 and the B. 1.351 variant in mice

DR Martinez, A Schäfer, SR Leist, D Li, K Gully… - Cell Reports, 2021 - ncbi.nlm.nih.gov
Improving clinical care for individuals infected with SARS-CoV-2 variants is a global health
priority. Small-molecule antivirals like remdesivir (RDV) and biologics such as human …

Prevention and therapy of SARS-CoV-2 and the B. 1.351 variant in mice

DR Martinez, A Schäfer, SR Leist, D Li, K Gully… - 2021 - agris.fao.org
Improving clinical care for individuals infected with SARS-CoV-2 variants is a global health
priority. Small-molecule antivirals like remdesivir (RDV) and biologics such as human …
[PDF] archive.org

[PDF][PDF] Prevention and therapy of SARS-CoV-2 and the B. 1.351 variant in mice

DR Martinez, A Schafer, SR Leist, D Li, K Gully… - Cell …, 2021 - scholar.archive.org
Improving clinical care for individuals infected with SARS-CoV-2 variants is a global health
priority. Smallmolecule antivirals like remdesivir (RDV) and biologics such as human …